Please select the option that best describes you:
Topics:
Medical Oncology • Supportive Care • Endocrinology • Bone and Calcium Disorders • Primary Care
Would you favor oral bisphosphonates over intravenous formulations for patients with hormone sensitive prostate cancer and androgen deprivation therapy (ADT) related osteopenia?
Answer from: at Academic Institution
If kidney function is normal, either would do. Therapy depends on the risk level. (See Cosman et al., PMID 39073912.)
Sign in or Register to read more